Timothy Snail is a panelist on the session entitled, “Defending Your Company Against Class Action Litigation.”
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
